Literature DB >> 32727486

A model of disparities: risk factors associated with COVID-19 infection.

Yelena Rozenfeld1, Jennifer Beam2, Haley Maier2, Whitney Haggerson2, Karen Boudreau2, Jamie Carlson2, Rhonda Medows3.   

Abstract

BACKGROUND: By mid-May 2020, there were over 1.5 million cases of (SARS-CoV-2) or COVID-19 across the U.S. with new confirmed cases continuing to rise following the re-opening of most states. Prior studies have focused mainly on clinical risk factors associated with serious illness and mortality of COVID-19. Less analysis has been conducted on the clinical, sociodemographic, and environmental variables associated with initial infection of COVID-19.
METHODS: A multivariable statistical model was used to characterize risk factors in 34,503cases of laboratory-confirmed positive or negative COVID-19 infection in the Providence Health System (U.S.) between February 28 and April 27, 2020. Publicly available data were utilized as approximations for social determinants of health, and patient-level clinical and sociodemographic factors were extracted from the electronic medical record.
RESULTS: Higher risk of COVID-19 infection was associated with older age (OR 1.69; 95% CI 1.41-2.02, p < 0.0001), male gender (OR 1.32; 95% CI 1.21-1.44, p < 0.0001), Asian race (OR 1.43; 95% CI 1.18-1.72, p = 0.0002), Black/African American race (OR 1.51; 95% CI 1.25-1.83, p < 0.0001), Latino ethnicity (OR 2.07; 95% CI 1.77-2.41, p < 0.0001), non-English language (OR 2.09; 95% CI 1.7-2.57, p < 0.0001), residing in a neighborhood with financial insecurity (OR 1.10; 95% CI 1.01-1.25, p = 0.04), low air quality (OR 1.01; 95% CI 1.0-1.04, p = 0.05), housing insecurity (OR 1.32; 95% CI 1.16-1.5, p < 0.0001) or transportation insecurity (OR 1.11; 95% CI 1.02-1.23, p = 0.03), and living in senior living communities (OR 1.69; 95% CI 1.23-2.32, p = 0.001).
CONCLUSION: sisk of COVID-19 infection is higher among groups already affected by health disparities across age, race, ethnicity, language, income, and living conditions. Health promotion and disease prevention strategies should prioritize groups most vulnerable to infection and address structural inequities that contribute to risk through social and economic policy.

Entities:  

Keywords:  COVID-19; Disparities; Infection; Multivariable model; Risk factors; Social determinants of health

Mesh:

Year:  2020        PMID: 32727486      PMCID: PMC7387879          DOI: 10.1186/s12939-020-01242-z

Source DB:  PubMed          Journal:  Int J Equity Health        ISSN: 1475-9276


Background

As U.S. states begin to reduce coronavirus social restrictions, the risk of contracting COVID-19 is likely to increase. While statistical models have been built to predict severity of illness and mortality related to COVID-19 infection [1], less has been done to predict the risk of initial infection in community settings. Studies to date have contained limited demographic information, have focused on hospitalized patients, and have not been representative of U.S. populations [2-7]. Most studies are limited to known clinical risk factors for severe illness and mortality, such older age [3, 4] and chronic health conditions such as hypertension [3], cardiovascular disease [4], and diabetes [7]. More recent research by the U.S. Centers for Disease Control and Prevention (CDC) has identified specific groups at higher risk for severe illness, such as older adults living in long term care facilities, those with a BMI of forty or higher, and immunosuppressed individuals, including people withHIV/AIDS [8]. However, most risk models have not incorporated clinical, sociodemographic, and environmental variables, which may be predictive of community spread within the U.S. As with other infectious diseases, predictors of COVID-19 infection may include employment status, education level, income, and housing conditions [9], which could influence the ability to seek care, adhere to treatment, and practice physical distancing measures. Thus, effective strategies for predicting risk factors for community transmission should include both clinical and social factors [10]. The latter factors in particular remain understudied, especially among communities of lower socioeconomic status [10]. Emerging data already show that communities of color and/or low socioeconomic status are experiencing disproportionate rates of serious illness if infected, due to pre-existing economic and health inequities [11, 12]. By performing large scale analyses, healthcare systems can play a role in investigating patient and population differences in disease susceptibility, distinct from mortality risk. The purpose of this study was to use collated data from an entire health system to identify the apparent sociodemographic and environmental, as well as clinical predictors of the risk of COVID-19 infection and their relevance to persistent health disparities across race, ethnicity, socioeconomic status, language, and age [13].

Methods

Study design and setting

This study was conducted at Providence Health System, the third largest not-for-profit health system in the U.S., servicing more than five million people across seven states located in the Western and Southwestern portion of the U.S.

Data source

Data were collected from the Providence enterprise data warehouse. The data elements that were collected were informed by a comprehensive review of prior scientific studies that documented mortality risk factors and the CDC list of groups at higher risk for severe illness [8]. Variables included patient demographic, social, and behavioral history information; chronic conditions documented in clinical history; current conditions; prescribed medications; laboratory testing results; and acute and ambulatory healthcare utilization. To study sociodemographic and environmental variables, electronic medical record (EMR) data was utilized to link patients’ locations to the U.S. Census Bureau’s 2018 American Community Survey and the CDC air quality data. To join these datasets to EMR data, patient addresses were geocoded, and matched at the census block group or tract level. Glottolog, a repository for the world’s languages, was used to assign language groups. Geographic regions and clinical symptoms were also included as variables. Census data on educational attainment and financial insecurity were used to assess socioeconomic status.

Participants and procedures

Patients residing in Alaska, Washington, Oregon, Montana, and California (Los Angeles and parts of Orange County) who were tested for acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection between February 28, 2020 and April 27, 2020 were included in the data set. Testing mechanisms included swabs from respiratory specimens appropriate for viral RNA testing from eight testing platforms.

Outcomes and predictors

The principle dependent variable for our model was COVID-19 infection, as indicated by a positive lab test. Distributions of all continuous variables including age, BMI, number of medications, and neighborhood financial insecurity were examined for normality and transformed into categorical attributes. Comorbidities were determined by problem list documentation or clinical encounter diagnoses using standard International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) nomenclature and further summarized into a measure of disease severity using total number of chronic conditions. Substance, tobacco, and alcohol consumptions were captured from social history assessments and clinician documentation. The following variables were used as indicators of physical proximity to other people (i.e., structural barriers to social distancing): transportation insecurity, relationship status, employment, housing insecurity, and age-stratified communal living.

Statistical methods and modeling

Descriptive statistics were used to summarize study participants. Continuous variables were described by means and standard deviations, while categorical variables were described using frequencies and percentages. We conducted bivariate analysis to assess a significant effect of each factor on the outcome. All covariates with p < 0.25 in the bivariate analysis were considered for model inclusion since use of a more traditional level of 0.05 often fails to identify variables whose association with the outcome could become stronger in the presence of other variables [14]. In addition, all variables of known clinical importance found in previous studies that could make an important contribution were included to improve upon previous models [1]. Beginning with all variables of interest, a stepwise selection with backward elimination was used to create a multivariable logistic regression model for predicting risk of infection. Initial parameters for the model were identified in the training set and then tested at the subsequent step, with data randomly partitioned into two independent data subsets: 80% for training and building the model and another 20% for testing. Missing data was recoded as unknown and included in the analysis. Detailed covariate definitions and data sources are shown in the supplement. The model’s ability to discriminate COVID-19 infection in the validation data set was evaluated using the area under the receiver operating characteristic curve and Hosmer-Lemeshow goodness-of-fit statistic. The observed and expected frequencies within each decile of risk was compared [14]. All data manipulation and modeling were completed in SAS EG (SAS Institute, Carry NC). For all independent predictor subgroups, the risk of COVID-19 infection was quantified with odds ratios (OR) and 95% confidence intervals. These risks were calculated using the entire data set.

Results

Study population

A total of 34,503 COVID-19 tested patients were included in the study (Table 1). The average age was 50 years old (SD 20), 59.6% (21,209) were female, 12% (4183) were identified as non-white race, and 66% (22,610) had at least one comorbidity. Within the study population, 7.5% (2578) patients tested positive and 92.5% (31,925) tested negative for COVID-19. Of patients testing positive, 36% (924) were hospitalized and 9% (240) died during the study period.
Table 1

Study Participant Demographics and Characteristic

Tested patients(N = 34,503)Tested Positive(N = 2578)Tested Negative(31,925)
N%N%N%
Sociodemographic
Age
  < 1813934.0351.413584.3
 18–29449413.026810.4422613.2
 30–39580316.830411.8549917.2
 40–49546815.841115.9505715.8
 50–59566316.452320.3514016.1
 60–69546715.846718.1500015.7
 70–79352210.229611.5322610.1
 80+26937.827410.624197.6
Gender
 Female21,20959.6135252.419,21960.2
 Male13,92440.4122547.512,69939.8
Education
 Education < 12 years956527.782632.0873927.4
Employment
 Student11483.3512.010973.4
 Employed16,57048.0131150.915,25947.8
 Not Employed587217.036214.0551017.3
 Retired728421.163724.7664720.8
 Unknown362910.52178.4341210.7
Race
 White24,79971.9143755.723,36273.2
 American Indian | Alaska Native4651.3130.54521.4
 Asian17135.02098.115044.7
 Black | African American16494.81596.214904.7
 Native Hawaiian | Pacific Islander3561.0251.03311.0
 Unknown552116.073528.5478615.0
Ethnicity
 Other Ethnic Groups30,93889.7194075.328,99890.8
 Hispanic or Latino356510.363824.729279.2
Religious Affiliation
 Agnostic10,93831.766125.610,27732.2
 Christian14,48342.0121947.313,26441.5
 Other Religion11813.41034.010783.4
 Unknown790122.959523.1730622.9
Relationship
 Single12,94037.579030.612,15038.1
 Divorced or Legally Separated524815.238314.9486515.2
 Married or Significant Other15,17344.0130550.613,86843.4
 Unknown11423.31003.910423.3
Language
 English32,27793.5208580.930,19294.6
 Sino-Tibetan2860.8552.12310.7
 Spanish10223.029111.37312.3
 Other Languages9182.71475.77712.4
Clinical
Body Mass Index
 Normal708820.544417.2664420.8
 Underweight5541.6301.25241.6
 Moderately Obese566716.445217.5521516.3
 Overweight800923.267026.0733923.0
 Severely Obese30808.92439.428378.9
 Very Severely Obese28358.22088.126278.2
 Unknown727021.153120.6673921.1
Number of Chronic Conditions
 011,89334.5101739.410,87634.1
 1–212,18535.392435.811,26135.3
 3–4656319.040615.7615719.3
 5+386211.22319.0363111.4
Clinical Diagnosis
 Diagnosis of Diabetes494214.345617.7448614.1
 Diagnosis of Kidney Disease650.260.2590.2
 Diagnosis of HIV/AIDS1410.4130.51280.4
 Diagnosis of Dementia10393.01355.29042.8
Polypharmacy
 0 Prescriptions893325.982632.0810725.4
 1–9 Prescriptions18,06652.4137053.116,69652.3
 10–19 Prescriptions530715.429811.6500915.7
 20–29 Prescriptions15494.5612.414884.7
 30+ Prescriptions6481.9230.96252.0
Mental Health and Substance Use
 History of Illicit Drug Use437512.71375.3423813.3
 History of Tobacco Use560616.21626.3544417.1
 Diagnosis of Serious Persistent Mental Illness450713.11776.9433013.6
 Diagnosis of Substance Use Disorder360510.41124.3349310.9
Primary Care Affiliation
 Internal Primary Care Provider14,68242.5589434.713,78843.2
 External Primary Care Provider12,45636.1102639.811,43035.8
 Unknown Primary Care Provider736521.3565825.5670721.0
 Electronic Communication through the EMR22,15864.2133751.920,82165.2
Symptoms
 Fever20,56559.6199577.418,57058.2
 Cough24,50671.0206280.022,44470.3
 Breath21,58762.6185772.019,73061.8
 Chills6942.0883.46061.9
 Myalgia9552.81455.68102.5
Environmental
Region
 Oregon10,48630.445417.610,03231.4
 Alaska18375.3863.317515.5
 Puget Sound627318.270427.3556917.4
 Southern California38521160523.5324710.2
 Washington | Montana12,05534.972928.311,32635.5
Age-Stratified Communal Living
 Non-Communal Living24,58171.2176668.522,81571.5
 Adult Community16194.71435.514764.6
 Adult and Youth529415.340015.5489415.3
 Multigenerational19705.71776.917935.6
 Senior Living4891.4582.24311.4
 Other5501.6341.35161.6
 Financial Insecurity999329.076829.8922528.9
 Housing Insecurity674319.570927.5603418.9
 Transportation Insecurity10,42930.281031.4961930.1
 Low Air Quality966428.075429.2891027.9
Study Participant Demographics and Characteristic

Risk factors

Table 2 shows the twenty-nine sociodemographic, clinical, and environmental covariates associated with odds of infection.
Table 2

Final Multivariable Model Results

OR95% CIp-value
Sociodemographic
Age
 18–29
  < 180.33[0.22–0.49]<.0001
 30–390.88[0.73–1.05]0.1574
 40–491.27[1.06–1.52]0.011
 50–591.69[1.41–2.02]<.0001
 60–691.65[1.36–2.01]<.0001
 70–791.59[1.24–2.05]0.0003
 80+1.64[1.24–2.17]0.0005
Gender
 Female
 Male1.32[1.21–1.44]<.0001
Education
 Education < 12 years1.02[1.01–1.14]0.0435
 Employment
 Student
 Employed1.85[1.39–2.46]<.0001
 Not Employed1.41[1.05–1.91]0.024
 Retired2.06[1.54–2.76]<.0001
 Unknown1.37[1–1.87]0.0494
Race
 White
 American Indian | Alaska Native0.63[0.36–1.12]0.1156
 Asian1.43[1.18–1.72]0.0002
 Black| African American1.51[1.25–1.83]<.0001
 Native Hawaiian | Pacific Islander1.02[0.66–1.57]0.9438
 Unknown1.34[1.18–1.52]<.0001
Ethnicity
 Other Ethnic Groups
 Hispanic or Latino2.07[1.77–2.41]<.0001
Religious Affiliation
 Agnostic
 Christian1.28[1.15–1.43]<.0001
 Other Religion1.01[0.77–1.24]0.1453
 Unknown1.10[0.97–1.25]0.8752
Relationship
 Single
 Divorce or Legally Separated1.08[0.93–1.26]0.3293
 Married or Significant Other1.12[1.01–1.25]0.0357
 Unknown0.96[0.74–1.24]0.7468
Language
 English
 Sino-Tibetan1.98[1.38–2.84]0.0002
 Spanish1.60[1.31–1.94]<.0001
 Other Languages2.09[1.7–2.57]<.0001
Clinical
Body Mass Index
 Normal
 Underweight0.80[0.54–1.2]0.2857
 Moderately Obese1.25[1.08–1.45]0.0033
 Overweight1.28[1.12–1.46]0.0003
 Severely Obese1.45[1.21–1.73]<.0001
 Very Severely Obese1.58[1.31–1.91]<.0001
 Unknown0.99[0.84–1.16]0.8867
Number of Chronic Conditions
 0
 1–20.83[0.74–0.93]0.001
 3–40.63[0.54–0.74]<.0001
 5+0.55[0.44–0.69]<.0001
Clinical Diagnosis
 Diagnosis of Diabetes1.40[1.22–1.61]<.0001
 Diagnosis of Kidney Disease1.03[1.01–2.3]0.0385
 Diagnosis of HIV/AIDS1.43[1.03–2.63]0.0252
 Diagnosis of Dementia2.01[1.61–2.51]<.0001
Polypharmacy
 0 Prescriptions
 1–9 Prescriptions0.76[0.68–0.86]<.0001
 10–19 Prescriptions0.60[0.5–0.71]<.0001
 20–29 Prescriptions0.43[0.32–0.59]<.0001
 30+ Prescriptions0.42[0.26–0.66]0.0002
Mental Health and Substance Use
 History of Illicit Drug Use0.63[0.53–0.77]<.0001
 History of Tobacco Use0.46[0.38–0.54]<.0001
 Diagnosis of Serious Persistent Mental Illness0.77[0.65–0.92]0.003
 Diagnosis of Substance Use Disorder0.70[0.56–0.87]0.001
Primary Care Provider Affiliation
 Internal Primary Care Provider
 External Primary Care Provider1.23[1.1–1.37]0.0004
 Unknown Primary Care Provider1.27[1.11–1.46]0.0005
 Electronic Communication through the EMR0.72[0.66–0.8]<.0001
Symptoms
 Symptoms of Fever2.39[2.15–2.65]<.0001
 Symptoms of Cough1.44[1.28–1.62]<.0001
 Shortness of Breath1.34[1.21–1.49]<.0001
 Symptoms of Chills1.40[1.09–1.79]0.0086
 Myalgia1.80[1.47–2.2]<.0001
Environmental
Region
 Oregon
 Alaska1.31[1–1.7]0.0469
 Puget Sound2.83[2.44–3.28]<.0001
 Southern California2.39[2.06–2.78]<.0001
 Washington Montana1.49[1.29–1.73]<.0001
Age-Stratified Communal Living
 Non-Communal Living
 Adult Community1.30[1.07–1.58]0.0082
 Adult and Youth1.07[0.95–1.21]0.2835
 Multigenerational1.07[0.9–1.28]0.4563
 Senior Living1.69[1.23–2.32]0.0011
 Other1.12[0.77–1.64]0.5492
 Financial Insecurity1.10[1.01–1.25]0.0392
 Housing Insecurity1.32[1.16–1.5]<.0001
 Transportation Insecurity1.11[1.02–1.23]0.0285
 Low Air Quality1.01[1–1.04]0.0502
Final Multivariable Model Results

Sociodemographic risk factors

Comparatively, individuals between 50 and 59 years of age (OR 1.69; 95% CI 1.41–2.02, p < 0.0001) or male gender (OR 1.32; 95% CI 1.21–1.44, p < 0.0001) were more likely to contract COVID-19. Being employed (OR 1.85; 95% CI 1.39–2.46, p = 0.02), or retired (OR 2.06; 95% CI 1.54–2.76, p < 0.0001) was associated with higher levels of infection. Asian race (OR 1.43; 95% CI 1.18–1.72, p = 0.0002), Black/African American race (OR 1.51; 95% CI 1.25–1.83, p < 0.0001), and Latino ethnicity (OR 2.07; 95% CI 1.77–2.41, p < 0.0001) were more likely than whites to contract COVID-19. Individuals who identified as being married or having a significant other were at higher infection risk (OR 1.12; 95% CI 1.01–1.25, p = 0.04), as were those whose primary language was not English (OR 2.09; 95% CI 1.7–2.57, p < 0.0001), and those who self-reported their religious affiliation as Christian denomination (OR 1.28; 95% CI 1.15–1.43, p < 0.0001).

Clinical risk factors

Clinical risk factors including being very severely obese (OR 1.58; 95% CI 1.31–1.91, p < 0.0001), or having been diagnosed with diabetes (OR 1.40; 95% CI 1.22–1.61, p < 0.0001), chronic kidney disease (OR 1.03; 95% CI 1.01–2.3, p = 0.04), dementia (OR 2.01; 95% CI 1.61–2.51, p < 0.0001), or HIV/AIDS (OR 1.43; 95% CI 1.03–2.63, p = 0.03). Having an external primary care provider (OR 1.23; 95% CI 1.1–1.37, p = 0.0004) or an unknown primary care provider (OR 1.27; 95% CI 1.11–1.46, p = 0.0005) were associated with higher infection risk compared to having a primary care provider within the Providence Health System. Receiving electronic communication through the EMR was associated with a lower infection risk (OR 0.72; 95% CI 0.66–0.8, p < 0.0001).

Environmental risk factors

Patients living in areas with low air quality (OR 1.01; 95% CI 1.0–1.04, p = 0.05), financial insecurity (OR 1.10; 95% CI 1.01–1.25, p = 0.04), transportation insecurity (OR 1.11; 95% CI 1.02–1.23, p = 0.03), or housing insecurity (OR 1.32; 95% CI 1.16–1.5, p < 0.0001) were at higher risk of infection. Living in senior living facilities was associated with greater infection risk (OR 1.69; 95% CI 1.23–2.32, p = 0.001).

Prediction of infection risk

The model performed consistently across training and testing data sets with a receiver operating characteristic area under the curve of 0.78 and the Hosmer-Lemeshow chi-square of 4.4 (p = 0.81). The probabilities of infection was partitioned into “deciles of risk” (i.e. equal groups from smallest to the largest) did not highlight any “underperforming” areas.

Discussion

Clinical risk factors

This retrospective study of the risk of COVID-19 infection identified several clinical risk factors also associated with serious illness in prior studies, including older age [3], male gender [15], diabetes [7], chronic kidney disease [16], high BMI [17], and immunosuppression [18]. However, some factors previously found to increase mortality risk, such as hypertension [3], and cardiovascular disease, liver disease, lung disease, or asthma [8], were not significant factors associated with initial COVID-19 infection. Surprisingly, being prescribed more than ten medications or having a greater number of chronic conditions was associated with less infection risk, suggesting possible risk reduction behavior based on perceived risk. Further research is needed to understand the differences between factors associated with initial infection risk and those associated with serious illness and mortality once the infection occurs. Healthcare access through a relationship with an internal primary care provider was associated with a lower infection risk; however, this may be a result of higher rates of testing for COVID-19 compared to individuals with no primary care provider. Patients without a primary care provider may have only been tested for COVID-19 after respiratory and other possible COVID-19 symptoms became conspicuous, thus increasing the probability of a positive test. Receiving secure electronic communication through the EMR was associated with lower risk of infection, suggesting that access to health advice and education may reduce risk. Serious mental illness and drug and tobacco use were associated with lower risk; however further study is necessary to understand the mechanisms behind such associations. Race and ethnicity appeared to be important predictors of risk. Higher risk of infection among Black, indigenous, and/or people of color may be associated with other sociodemographic and environmental characteristics found to also be significant in this study. African Americans and Latinos are more likely to live in communities with poor air quality [19], work in jobs that cannot telecommute [20], and lack access to healthcare [21] which may increase the risk of infection and contribute to racial disparities in mortality. Additionally, chronic conditions such as obesity, stroke, and diabetes, and premature death also affect African Americans and Latinos disproportionately compared to whites [13]. Communities of color are also more likely to experience lower socioeconomic status [22], and be employed as essential workers [10]. Additionally, for these and other vulnerable groups, lack of personal transportation is both a barrier to healthcare access [23] and social distancing, further exacerbating infection risk. For these reasons, communities of color experience more structural barriers to social distancing measures and are more vulnerable to severe illness. Having limited English proficiency can be a barrier to accessing health services and understanding health information, especially when written translations and/or trained translators are not available [24]. Over the course of the pandemic, health information has changed rapidly (e.g., mandates for masking), which can create barriers to accessing information and could leave indigenous and immigrant communities uninformed. During the Ebola epidemic in West Africa, language barriers were an obstacle to slowing the spread of the disease [25]. People with LEP are also more likely to have low health literacy compared to English speakers and are at a higher risk of poor health [26]. Culturally and linguistically appropriate interventions are essential, including communication materials of differentformats and reading levels developed through the collaboration of native language speakers and English speakers, as well as the use of community health workers that can engage with underserved groups [27].

Environmental risk factors

Older age may be considered both a clinical and an environmental risk factor, as it moderates both comorbidities (e.g., dementia) requiring caregiving and housing situations (e.g., living in senior communities). Our results showed that some sociodemographic patient characteristics that influence environmental exposure to social contact were also associated with increased rates of COVID-19 infection, such as being married or having a significant other, being employed, lacking access to a personal vehicle, and living in overcrowded housing, each of which significantly increased infection risk. Religious affiliation was also associated with increased risk, which may be attributed to attendance of large religious services or other behaviors associated with religious identity. People experiencing housing insecurity may experience challenges with physical distancing, especially when housing is crowded. These individuals may also lack hand washing facilities and/or running water [28]. Both factors could facilitate community spread of infectious diseases. Regional differences in infection risk were evident, with Southern California and the Western Washington having the highest infection rates (15.7 and 11.3% of tested patients) while Oregon and Alaska (4.3 and 4.7%) had the lowest rates. These regional differences may reflect some combination of population density, proximity to the initial points of COVID-19 entry into the U.S., and state-specific COVID-19 precautions.

Study limitations

This study was limited to patient data from the Providence Health System, and publicly available data sets. Although the organization serves a diverse patient population across seven Western U. S states, the generalizability of this study to the entire U.S is unclear. With limited testing available and evolving screening guidelines, clinical discernment and personal bias may have impacted which individuals received testing and thus may have influenced the rates of testing in certain populations. Additionally, it is impossible to correlate patient data to measures of individual patient behaviors, such as mask use or adherence to social distancing recommendations. Finally, this study focused on factors associated with initial infection risk, however other factors may further influence outcomes such as disease severity, time in hospital, and mortality.

Conclusions

Our construction of a multi-faceted prediction model of COVID-19 infection risk in our large, multi-state population has important implications for healthcare systems, public health departments, and city and state governments to further reduce the risk of infection and prevent the spread of COVID-19 in communities that may be disproportionately impacted. Knowledge of the complex mixture of clinical, ethnic, linguistic, and environmental factors that contribute to infection risk should enable more targeted public health approaches to decrease COVID-19 infection. Linguistically and culturally appropriate prevention education, healthcare access including routine care and COVID-19 testing, and efforts to address substandard housing and hazardous working conditions are essential to reducing risk among vulnerable groups, especially communities of lower socioeconomic status which experience a greater incidence of infectious diseases [29]. Now, and as communities seek to “re-open,” addressing the disparities in infection that contribute to rates of serious illness and mortality are needed to alleviate the disproportionate burden of the pandemic and persisting health disparities. Additional file 1. Model Covariate Definitions and Sources.
  20 in total

1.  Promoting health: intervention strategies from social and behavioral research.

Authors:  B D Smedley; S L Syme
Journal:  Am J Health Promot       Date:  2001 Jan-Feb

Review 2.  Environmental health disparities in housing.

Authors:  David E Jacobs
Journal:  Am J Public Health       Date:  2011-05-06       Impact factor: 9.308

3.  Risk Factors Associated With Clinical Outcomes in 323 Coronavirus Disease 2019 (COVID-19) Hospitalized Patients in Wuhan, China.

Authors:  Ling Hu; Shaoqiu Chen; Yuanyuan Fu; Zitong Gao; Hui Long; Hong-Wei Ren; Yi Zuo; Jie Wang; Huan Li; Qing-Bang Xu; Wen-Xiong Yu; Jia Liu; Chen Shao; Jun-Jie Hao; Chuan-Zhen Wang; Yao Ma; Zhanwei Wang; Richard Yanagihara; Youping Deng
Journal:  Clin Infect Dis       Date:  2020-11-19       Impact factor: 9.079

4.  Health disparities: gaps in access, quality and affordability of medical care.

Authors:  Wayne J Riley
Journal:  Trans Am Clin Climatol Assoc       Date:  2012

5.  [Clinical characteristics and outcomes of 112 cardiovascular disease patients infected by 2019-nCoV].

Authors:  Y D Peng; K Meng; H Q Guan; L Leng; R R Zhu; B Y Wang; M A He; L X Cheng; K Huang; Q T Zeng
Journal:  Zhonghua Xin Xue Guan Bing Za Zhi       Date:  2020-06-24

6.  Temporal trends in air pollution exposure inequality in Massachusetts.

Authors:  Anna Rosofsky; Jonathan I Levy; Antonella Zanobetti; Patricia Janulewicz; M Patricia Fabian
Journal:  Environ Res       Date:  2017-11-02       Impact factor: 6.498

7.  Predictive factors for disease progression in hospitalized patients with coronavirus disease 2019 in Wuhan, China.

Authors:  Jun Zhang; Miao Yu; Song Tong; Lu-Yu Liu; Liang-V Tang
Journal:  J Clin Virol       Date:  2020-04-28       Impact factor: 3.168

8.  Chronic kidney disease is associated with severe coronavirus disease 2019 (COVID-19) infection.

Authors:  Brandon Michael Henry; Giuseppe Lippi
Journal:  Int Urol Nephrol       Date:  2020-03-28       Impact factor: 2.370

Review 9.  Importance of collecting data on socioeconomic determinants from the early stage of the COVID-19 outbreak onwards.

Authors:  Saman Khalatbari-Soltani; Robert C Cumming; Cyrille Delpierre; Michelle Kelly-Irving
Journal:  J Epidemiol Community Health       Date:  2020-05-08       Impact factor: 3.710

10.  Prediction models for diagnosis and prognosis of covid-19: systematic review and critical appraisal

Authors:  Laure Wynants; Ben Van Calster; Gary S Collins; Richard D Riley; Georg Heinze; Ewoud Schuit; Marc M J Bonten; Darren L Dahly; Johanna A A Damen; Thomas P A Debray; Valentijn M T de Jong; Maarten De Vos; Paul Dhiman; Maria C Haller; Michael O Harhay; Liesbet Henckaerts; Pauline Heus; Michael Kammer; Nina Kreuzberger; Anna Lohmann; Kim Luijken; Jie Ma; Glen P Martin; David J McLernon; Constanza L Andaur Navarro; Johannes B Reitsma; Jamie C Sergeant; Chunhu Shi; Nicole Skoetz; Luc J M Smits; Kym I E Snell; Matthew Sperrin; René Spijker; Ewout W Steyerberg; Toshihiko Takada; Ioanna Tzoulaki; Sander M J van Kuijk; Bas van Bussel; Iwan C C van der Horst; Florien S van Royen; Jan Y Verbakel; Christine Wallisch; Jack Wilkinson; Robert Wolff; Lotty Hooft; Karel G M Moons; Maarten van Smeden
Journal:  BMJ       Date:  2020-04-07
View more
  75 in total

1.  Vaccines and Variants, Valiance and Variance.

Authors:  Sarah Kemble; Desmond Edward; Lola H Irvin; Catherine M Pirkle
Journal:  Hawaii J Health Soc Welf       Date:  2021-10

2.  Disparities among smokers during the COVID-19 pandemic: Examination of COVID-19-related worries by sociodemographic factors in a U.S. Nationally representative survey.

Authors:  Robert T Fairman; Scott R Weaver; Amy L Nyman; Lucy Popova; Zachary Massey; Reed M Reynolds; Claire A Spears
Journal:  Prev Med Rep       Date:  2022-05-19

3.  Association of Lung CT Findings in Coronavirus Disease 2019 (COVID-19) With Patients' Age, Body Weight, Vital Signs, and Medical Regimen.

Authors:  Abdel-Ellah Al-Shudifat; Ali Al-Radaideh; Shatha Hammad; Nawal Hijjawi; Shaden Abu-Baker; Mohammed Azab; Reema Tayyem
Journal:  Front Med (Lausanne)       Date:  2022-06-30

4.  The COVID-19 pandemic and associated increases in experiences of assault violence among black men with low socioeconomic status living in Louisiana.

Authors:  Kaylin Beiter; Denise Danos; Erich Conrad; Stephanie Broyles; Jovanny Zabaleta; Jason Mussell; Stephen Phillippi
Journal:  Heliyon       Date:  2022-07-19

5.  Racial and Ethnic Disparities in Hospital Admissions from COVID-19: Determining the Impact of Neighborhood Deprivation and Primary Language.

Authors:  Nicholas E Ingraham; Laura N Purcell; Anthony Charles; Christopher J Tignanelli; Basil S Karam; R Adams Dudley; Michael G Usher; Christopher A Warlick; Michele L Allen; Genevieve B Melton
Journal:  J Gen Intern Med       Date:  2021-05-18       Impact factor: 5.128

6.  The Association Between Neighborhood Social Vulnerability and COVID-19 Testing, Positivity, and Incidence in Alabama and Louisiana.

Authors:  Gabriela R Oates; Lucia D Juarez; Ronald Horswell; San Chu; Lucio Miele; Mona N Fouad; William A Curry; Daniel Fort; William B Hillegass; Denise M Danos
Journal:  J Community Health       Date:  2021-05-09

7.  Social Determinants and Indicators of COVID-19 Among Marginalized Communities: A Scientific Review and Call to Action for Pandemic Response and Recovery.

Authors:  Whitney S Brakefield; Olufunto A Olusanya; Brianna White; Arash Shaban-Nejad
Journal:  Disaster Med Public Health Prep       Date:  2022-05-02       Impact factor: 5.556

8.  Ethnicity and clinical outcomes in COVID-19: A systematic review and meta-analysis.

Authors:  Shirley Sze; Daniel Pan; Clareece R Nevill; Laura J Gray; Christopher A Martin; Joshua Nazareth; Jatinder S Minhas; Pip Divall; Kamlesh Khunti; Keith R Abrams; Laura B Nellums; Manish Pareek
Journal:  EClinicalMedicine       Date:  2020-11-12

9.  [Social inequalities in the regional spread of SARS-CoV-2 infections].

Authors:  Nico Dragano; Jens Hoebel; Benjamin Wachtler; Michaela Diercke; Thorsten Lunau; Morten Wahrendorf
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2021-07-23       Impact factor: 1.513

10.  Differential impact of mitigation policies and socioeconomic status on COVID-19 prevalence and social distancing in the United States.

Authors:  Hsien-Yen Chang; Wenze Tang; Elham Hatef; Christopher Kitchen; Jonathan P Weiner; Hadi Kharrazi
Journal:  BMC Public Health       Date:  2021-06-14       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.